SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's polypill halves heart disease and stroke risk in trial

26 May 2011 Evaluate

Dr Reddy's four-in-one combination pill designed to ward off heart problems can halve the risk of heart disease and stroke, found in an international trial. The trial tested the effectiveness and tolerability of the 'polypill' in 378 people who had a raised risk of heart disease but did not necessarily have high blood pressure or cholesterol.

According to researchers, the benefits of the polypill, while large, were not as big as previous studies had suggested, and the side effects were also not as rare as first thought. In the short term, around one in six people in the trial experienced side effects. Although most were mild, about one in 20 people stopped treatment because of them. So the polypill might be best targeted at people with a raised heart disease risk, since the benefits would be more likely to outweigh the side-effect risk.

The polypill contains four established drugs aspirin, a cholesterol-lowering medication called simvastatin, and two other medicines known to lower blood pressure. The medicines are currently prescribed separately to millions of patients and are known to significantly cut the risk of disease, but many experts think combining them into a single pill might encourage people to take the medicines more reliably. 

Dr. Reddys Lab Share Price

1220.75 -11.50 (-0.93%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×